Alpelisib-produced by Piqray India is a generic drug

Alpelisib (Alpelisib) - the original research drug produced by Piqray India, is produced by Novartis Ltd/Swiss Novartis Pharmaceuticals. There is currently no Indian version of the generic version of Alpelisib on the market. Apelvis is a targeted therapy that can be used to treat estrogen receptor-positive and HER2-negative breast cancers with changes (mutations) in a gene called PIK3CA. The difference between it and the European version of the original drug Apelvis may lie in different packaging, different specifications, etc. The price of the drug on the market may still be different in different regions, but the drug ingredients are the same. The price of each box of 150mg*28 tablets may be more than 5,000 yuan (the price may fluctuate due to the exchange rate).